The Valley Desk

NCT02559817 · Interventional trial

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation

Overall registry status Terminated

Phase 2

Conditions Irritable Bowel Syndrome With Constipation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov